Literature DB >> 375674

Influence of O and K antigens on the surface properties of Escherichia coli in relation to phagocytosis.

O Stendahl, B Normann, L Edebo.   

Abstract

Strains of Escherichia coli with different O and K antigens were investigated with respect to physicochemical surface characteristics and liability to phagocytosis. Using two-phase partitioning analysis for the surface characterization, three main groups of strains emerged: Group I (O1:K1, O2:K1, O3:K2ab) showing both smooth hydrophilic O antigens and negatively-charged K antigen which rendered the strains maximally resistant to phagocytosis. Group II (O55:K59, O111:K58) showed no acidic K antigen but only smooth hydrophilic O antigen properties. However, these strains were as resistant to phagocytosis as the strains in group I. A third group (O14:K7, O24:K +) contained strains with rough, hydrophobic O antigen and negatively-charged K antigen. When the K antigen was removed by heat treatment these strains became more sensitive to phagocytosis. Certain other strains (O28:K-, O56:K + and O118:K-) did not fit into the three groups. These experiments show that the physicochemical surface effects and biological significance of the K antigen must be evaluated in relation to the properties conveyed by the corresponding O antigens.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 375674     DOI: 10.1111/j.1699-0463.1979.tb02408.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand B        ISSN: 0105-0656


  19 in total

1.  Loss of resistance to ingestion and phagocytic killing by O(-) and K(-) mutants of a uropathogenic Escherichia coli O75:K5 strain.

Authors:  S M Burns; S I Hull
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Urinary pathogenicity of Proteus mirabilis strains isolated from faeces or urine.

Authors:  P G Peerbooms; A M Verweij; P L Oe; D M MacLaren
Journal:  Antonie Van Leeuwenhoek       Date:  1986       Impact factor: 2.271

3.  Loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo.

Authors:  T A Russo; G Sharma; C R Brown; A A Campagnari
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

4.  Isoelectric points and surface hydrophobicity of Gram-positive cocci as determined by cross-partition and hydrophobic affinity partition in aqueous two-phase systems.

Authors:  H Miörner; P A Albertsson; G Kronvall
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

5.  Effect of specific binding of human albumin, fibrinogen, and immunoglobulin G on surface characteristics of bacterial strains as revealed by partition experiments in polymer phase systems.

Authors:  H Miörner; E Myhre; L Björck; G Kronvall
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

6.  Physicochemical surface properties of Escherichia coli strains isolated from different types of urinary tract infections.

Authors:  L Ohman; B Normann; O Stendahl
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

7.  Bacterial virulence versus host resistance in the urinary tracts of mice.

Authors:  C Svanborg-Edén; L Hagberg; R Hull; S Hull; K E Magnusson; L Ohman
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

8.  Physicochemical surface properties of elementary bodies from different serotypes of chlamydia trachomatis and their interaction with mouse fibroblasts.

Authors:  G Söderlund; E Kihlström
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

9.  Surface properties of Chlamydia psittaci.

Authors:  D W Vance; T P Hatch
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

10.  K-1 antigen content and the presence of an additional sialic acid-containing antigen among bacteremic K-1 Escherichia coli: correlation with susceptibility to opsonophagocytosis.

Authors:  P Stevens; C L Chu; L S Young
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.